SCHEMBL6185686

SCHEMBL6185686

CCCCC(=O)Nc1ccc2[nH]c(C)c(C(=O)c3c(Cl)cccc3Cl)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAPK3 O43293 1/20 0.48
STK17B O94768 1/20 0.48
DAPK1 P53355 1/20 0.48
STK17A Q9UEE5 1/20 0.48
DAPK2 Q9UIK4 1/20 0.48
F2R P25116 4/20 0.47
P2RY12 Q9H244 2/20 0.46
ALDH1A1 P00352 5/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HPGD P15428 3/20 0.44
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188945 0.82 KMT2A (0.44) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6186843 0.81 ALDH1A1 (0.40) ALDH1A1HPGDKMT2ARAB9AKDM4E
SCHEMBL6187358 0.81 F2R (0.51) DAPK3STK17BDAPK1STK17ADAPK2
SCHEMBL6185825 0.81 TYK2 (0.45) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL6189327 0.80 HPGD (0.46) DAPK3STK17BDAPK1STK17ADAPK2
SCHEMBL6185706 0.79 MAOB (0.42) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL6186285 0.78 MAOA (0.49) STK17BSTK17AALDH1A1SMN1; SMN2KDM4E
SCHEMBL6186608 0.78 ALDH1A1 (0.42) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL6185134 0.77 MAOA (0.54) STK17BSTK17AALDH1A1HPGDLMNA
SCHEMBL6188852 0.75 RAB9A (0.55) ALDH1A1LMNAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed